(Q44673679)

English

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension (English)

1 reference

Europe PubMed Central

5 December 2017

randomized controlled trial

1 reference

based on heuristic

inferred from title

Scott M Whitcup

4

object named as

Scott M Whitcup

1 reference

Europe PubMed Central

5 December 2017

author name string

Anne L Coleman

1

1 reference

Europe PubMed Central

5 December 2017

Fabian Lerner

2

1 reference

Europe PubMed Central

5 December 2017

Paula Bernstein

3

1 reference

Europe PubMed Central

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

110

1 reference

Europe PubMed Central

5 December 2017

12

1 reference

Europe PubMed Central

5 December 2017

2362-2368

1 reference

Europe PubMed Central

5 December 2017

The pharmacology of bimatoprost (Lumigan).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A rationale for lowering intraocular pressure in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Management and prognosis of end-stage glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure-dependent progression of visual field loss in advanced primary open-angle glaucoma: a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A useful testing strategy in phase III trials: combined test of superiority and test of equivalence

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular Beta-Blockers and Systemic Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological therapy for glaucoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost versus combined timolol and dorzolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900662-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(03)00662-6

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673679&oldid=2031309471"